Latest Articles

Publication Date
All News Scientific
'En bloc' peritoneal mesometrial resection (PMMR) and pelvic targeted compartmental lymphadenectomy (TCL) for management of patients with endometrial cancer - feasibility and safety study of a 'new kid on the block' in robotic surgery.

Robotic Peritoneal Mesometrial Resection and Targeted Compartmental Lymphadenectomy (PMMR + TCL) is a procedure following Cancer Field Surgery concept for endometrial cancer (EC), enabling superior locoregional control without adjuvant irradiation. …

Published: Oct. 21, 2025, midnight
Read Full Article
Cancer field surgery Complications Endometrial cancer PMMR Robot surgery Sentinel lymph node Targeted compartmental lymphadenectomy
Investors Show Faith In Faeth’s Cancer Metabolism Strategy As Data Read Out At ESMO - Citeline News & Insights

Investors Show Faith In Faeth’s Cancer Metabolism Strategy As Data Read Out At ESMO Citeline News & Insights

Published: Oct. 20, 2025, 10:35 p.m.
Read Full Article
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - The AI Journal

Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer The AI Journal

Published: Oct. 20, 2025, 9:33 p.m.
Read Full Article
Global Study Reports Rise in Several Cancers Among Adults of All Ages - MedPage Today

Global Study Reports Rise in Several Cancers Among Adults of All Ages MedPage Today

Published: Oct. 20, 2025, 9:27 p.m.
Read Full Article
Ibuprofen: How An Everyday Drug Might Offer Protection Against Cancer - Study Finds

Ibuprofen: How An Everyday Drug Might Offer Protection Against Cancer Study Finds

Published: Oct. 20, 2025, 3:54 p.m.
Read Full Article
Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer - Pulse 2.0

Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer Pulse 2.0

Published: Oct. 20, 2025, 3:54 p.m.
Read Full Article
Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer - Femtech Insider

Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer Femtech Insider

Published: Oct. 20, 2025, 2:27 p.m.
Read Full Article
ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability - Yahoo

ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability Yahoo

Published: Oct. 20, 2025, 2:07 p.m.
Read Full Article
ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability - Clinical Trials Arena

ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability Clinical Trials Arena

Published: Oct. 20, 2025, 1:12 p.m.
Read Full Article
Tondiamo Yellow Ribbon Lapel Pins Childhood Cancer Awareness Endometriosis Bone Cancer Brooch Pins for Public Charity Fundraiser Events Supplies Gifts - The San Joaquin Valley Sun

Tondiamo Yellow Ribbon Lapel Pins Childhood Cancer Awareness Endometriosis Bone Cancer Brooch Pins for Public Charity Fundraiser Events Supplies Gifts The San Joaquin Valley Sun

Published: Oct. 20, 2025, 12:36 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!